SEI Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.73M | Buy |
|
|||||
|
2025
Q2 | $3.28M | Sell |
|
|||||
|
2025
Q1 | $4.06M | Buy |
|
|||||
|
2024
Q4 | $4.14M | Sell |
|
|||||
|
2024
Q3 | $6.45M | Buy |
|
|||||
|
2024
Q2 | $3.77M | Buy |
|
|||||
|
2024
Q1 | $3.08M | Buy |
|
|||||
|
2023
Q4 | $3.13M | Buy |
|
|||||
|
2023
Q3 | $1.98M | Sell |
|
|||||
|
2023
Q2 | $3.03M | Buy |
|
|||||
|
2023
Q1 | $2.28M | Sell |
|
|||||
|
2022
Q4 | $3.2M | Buy |
|
|||||
|
2022
Q3 | $2.27M | Buy |
|
|||||
|
2022
Q2 | $1.66M | Buy |
|
|||||
|
2022
Q1 | $1.89M | Buy |
|
|||||
|
2021
Q4 | $320K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.98M | Sell |
|
|||||
|
2020
Q4 | $2.04M | Sell |
|
|||||
|
2020
Q3 | $1.9M | Sell |
|
|||||
|
2020
Q2 | $2.72M | Sell |
|
|||||
|
2020
Q1 | $1.76M | Buy |
|
|||||
|
2019
Q4 | $1.5M | Buy |
|
|||||
|
2019
Q3 | $959K | Sell |
|
|||||
|
2019
Q2 | $1.57M | Buy |
|
|||||
|
2019
Q1 | $718K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $0 | Sell |
|
|||||
|
2018
Q1 | $0 | Sell |
|
|||||
|
2017
Q4 | $115K | Buy |
|
|||||
|
2017
Q3 | $108K | Buy |
|
|||||
|
2017
Q2 | $125K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $65K | Sell |
|
|||||
|
2016
Q3 | $82K | Buy |
|
|||||
|
2016
Q2 | $47K | Buy |
|
|||||
|
2016
Q1 | $44K | Buy |
|
|||||
|
2015
Q4 | $9K | Sell |
|
|||||
|
2015
Q3 | $1.99M | Buy |
|
|||||
|
2015
Q2 | $385K | Buy |
|
|||||
|
2015
Q1 | $226K | Buy |
|